5 Best Small Cap Pharma Stocks to Invest In

4. Avadel Pharmaceuticals plc (NASDAQ:AVDL)

Number of Hedge Fund Investors In Q4 2023: 26

Avadel Pharmaceuticals plc (NASDAQ:AVDL) is an American firm that is developing treatments for sleep disorders. Its shares have erased a large portion of their gains made since April 2024 on the back of poor financial performance in the form of earnings misses. However, notable research firms such as UBS and Needham have rated the stock as Buy.

During December 2023, 26 out of the 933 hedge funds part of Insider Monkey’s database had invested in the firm. Avadel Pharmaceuticals plc (NASDAQ:AVDL)’s largest stakeholder in our database is Brian Ashford-Russell and Tim Woolley’s Polar Capital since it owns $95.3 million worth of shares.

Follow Avadel Pharmaceuticals Plc (NASDAQ:AVDL)